72162-2436-1 : NDC 2026 Code

72162-2436-1 : Chlordiazepoxide Hcl And Clidinium Bromide ( Chlordiazepoxide Hcl And Clidinium Bromide )

Additionally :

You can get information about “72162-2436-1” NDC code in 72162-2436-1 in HTML format

HTML | 72162-2436-1 in TXT (Plain Text) format

TXT | 72162-2436-1 in PDF (Portable Document Format)

PDF | 72162-2436-1 in XML format

XML formats.

NDC Code : 72162-2436-1 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "72162-2436-1",
    "PackageDescription": "100 CAPSULE in 1 BOTTLE (72162-2436-1) ",
    "NDC11Code": "72162-2436-01",
    "ProductNDC": "72162-2436",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Chlordiazepoxide Hcl And Clidinium Bromide",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Chlordiazepoxide Hcl And Clidinium Bromide",
    "DosageFormName": "CAPSULE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20221001",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA215835",
    "LabelerName": "Bryant Ranch Prepack",
    "SubstanceName": "CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE",
    "StrengthNumber": "5; 2.5",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]",
    "DEASchedule": "CIV",
    "Status": "Active",
    "LastUpdate": "2025-11-06",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250213",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}